Home › Waldenstrom Macroglobulinemia › New York › New York City
Waldenstrom Macroglobulinemia clinical trials in New York City, NY
6 studies for Waldenstrom Macroglobulinemia are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RecruitingPhase 1/2
- Columbia University Medical Center, New York
- Weill Cornell Medical College Newyork Presbyterian Hospital, New York
- Memorial Sloan Kettering Cancer Center Mskcc, New York
A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center, New York
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RecruitingPhase 1
- New York University (NYU) Clinical Cancer Center, New York
- Weill Cornell Medicine, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of ARC-02 in B-cell NHL
RecruitingPhase 1
- NYU Langone, New York
Study of SGR-1505 in Mature B-Cell Neoplasms
RecruitingPhase 1
- Weill Cornell, New York
Waldenstrom Macroglobulinemia trials in other cities
- Durham, NC10 studies
- Boston, MA9 studies
- Denver, CO7 studies
- Rochester, MN6 studies
- Houston, TX6 studies
- Dallas, TX6 studies
- Edison, NJ6 studies
- Seattle, WA5 studies
- Milwaukee, WI5 studies
- Washington, DC4 studies
- Baldwin Park, CA4 studies
- Columbus, OH4 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.